Đặc điểm lâm sàng và phương pháp xử trí bệnh nhân giảm ham muốn tình dục nữ điều trị tại Trung tâm Y học Giới tính Hà Nội

Hypoactive Sexual Desire Disorder (HSDD) is recognized as one of the most common female sexual dysfunctions, significantly impacting patients' quality of life, mental health, and marital relationships. Despite its prevalence, effective diagnosis and management remain challenging due to diverse etiologies and the complex interplay of various sexual dysfunctions. Early identification and timely intervention are crucial to mitigate long-term impacts, yet a universal treatment model is lacking. This study aims to delineate the clinical characteristics and evaluate the treatment approaches employed for female patients diagnosed with hypoactive sexual desire disorder at the Center for Sexual Medicine, Andrology and Fertility Hospital of Hanoi, thereby contributing to a better understanding and optimized care for this condition.

Healthcare professionals, researchers in sexual medicine, gynecologists, and psychologists specializing in sexual health.

This retrospective study investigated the clinical profiles and therapeutic strategies for 52 female patients presenting with hypoactive sexual desire disorder at the Center for Sexual Medicine in Hanoi from December 2022 to March 2025. Patients underwent comprehensive assessments including sexual history, the Female Sexual Function Index (FSFI), and the Female Sexual Distress Scale-Revised (FSDS-R), alongside documentation of interventions. The findings revealed an average patient age of 32.7 years, with a significant majority (86.5%) experiencing secondary hypoactive sexual desire disorder. Notably, 55.8% reported dissatisfaction with their sexual life, and 53.8% indicated an absence of foreplay during sexual activity. The mean FSFI score was 12.7, and the FSDS-R score was 16.5, underscoring the distress associated with the condition. Multimodal therapeutic approaches were widely utilized, including sex therapy (67.3%), pharmacological treatment (53.8%), psychological counseling (23.1%), and in a few cases, surgical intervention (3.8%). The study concludes that secondary hypoactive sexual desire disorder is predominant among affected women. Given the high heterogeneity of underlying causes and the frequent co-occurrence of multiple sexual dysfunctions, there is no single, universally applicable treatment model. The results emphasize the critical need for individualized, multimodal therapeutic strategies to achieve optimal outcomes for patients suffering from female sexual dysfunction, highlighting the importance of tailored interventions rather than a one-size-fits-all approach.